BCK Partners’s Thermo Fisher Scientific TMO Stock Holding History

BCK Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-427	Closed	-$236K	–	30
2024 Q2	$236K	Sell	427 -12	-3%	-$6.88K	0.12%	30
2024 Q1	$255K	Buy	439 +25	+6%	+$14K	0.14%	27
2023 Q4	$220K	Hold	414	–	–	0.12%	27
2023 Q3	$210K	Buy	+414	New	+$221K	0.13%	27
2023 Q2	–	Sell	-414	Closed	-$239K	–	28
2023 Q1	$239K	Hold	414	–	–	0.16%	26
2022 Q4	$228K	Hold	414	–	–	0.15%	27
2022 Q3	$210K	Hold	414	–	–	0.15%	28
2022 Q2	$225K	Buy	414 +4	+1%	+$2.2K	0.16%	24
2022 Q1	$242K	Hold	410	–	–	0.15%	26
2021 Q4	$274K	Hold	410	–	–	0.16%	24
2021 Q3	$234K	Hold	410	–	–	0.15%	24
2021 Q2	$207K	Buy	+410	New	+$193K	0.14%	26

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BCK Partners's TMO Position: Q3 2024 in Review

BCK Partners sold out of Thermo Fisher Scientific (TMO) in Q3 2024, closing a stake of 427 shares — an estimated $236K sold.

BCK Partners first reported a position in TMO in Q2 2021 and held it in 12 quarters. The position peaked at $274K in Q4 2021. 2,569 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

BCK Partners reported no remaining Thermo Fisher Scientific position as of Q3 2024 after selling out during the quarter.
BCK Partners sold 427 Thermo Fisher Scientific shares in Q3 2024, an estimated $236K.
BCK Partners first reported a position in Thermo Fisher Scientific in Q2 2021 and held it in 12 quarters.
BCK Partners's Thermo Fisher Scientific position peaked at $274K in Q4 2021.
2,569 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on BCK Partners's 13F filing for Q3 2024, filed 25 Oct 2024.